Leukoaraiosis is associated with functional impairment in older patients with Alzheimer's disease but not vascular dementia

Journal of Nutrition, Health and Aging

Volumn 10, Issue 1, 2006, Pages 31-35

  Ble, A ^a   Ranzini, M ^a   Zurlo, A ^b   Menozzi, L ^b   Atti, A R ^a   Munari, M R ^c   Volpato, S ^a   Scaramelli, G ^a   Fellin, R ^a   Zuliani, Giovanni ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^c CA FONCELLO HOSPITAL   (Italy)

Author keywords

Activities of daily living; Alzheimer's disease; Disability; Leukoaraiosis; Vascular dementia; White matter lesions

Indexed keywords

AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; BARTHEL INDEX; BEHAVIOR DISORDER; BRAIN ATROPHY; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DAILY LIFE ACTIVITY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; ELDERLY CARE; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; GAIT DISORDER; GENDER; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM;

EID: 31344437218     PISSN: 12797707     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Hachinski VC, Potter P, Merskey H. Leuko-araiosis. Arch Neurol 1987; 44: 21-23.
2. Awad IA, Spetzler RF, Kodak JA Awad CA, Carey R. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly, I: correlation with age and cerebrovascular risk factors. Stroke 1986; 17: 1084-1089.
3. Junque C, Pujol J, Ribas JC, Capdevila A, Marti- Vilalta JL. Leukoaraiosis on magnetic resonance imaging and speed of mental processing. Arch Neurol 1990; 47: 151-156.
4. Tatemichi TK, Desmond DW. Epidemiology of vascular dementia; in Prohovnik I, Wade J, Knezevick S, Tatemichi T, Erkinjuntti T: Vascular Dementia. Current Concepts. Chichester, Wiley, 1996, 41-47.
5. Inzitari D, Diaz F, Fox A et al.: Vascular risk factors and leukoaraiosis. Arch Neurol 1987; 44: 42-47.
6. Swayze VW II, Andreasen NC, Alliger RJ, Ehrhardt JC, Yuh WTC. Structural brain abnormalities in bipolar affective disorder. Arch Gen Psychiatry 1990; 47: 1054-1059.
7. Hickie I, Scott E, Mitchell P, Wilhelm K, Austin MP, Bennett B. Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry 1995; 37: 151-160.
8. Brown FW, Lewine RJ, Hudgins PA, Risch SC. White matter hyperintensity signals in psychiatric and non psychiatric subjects. Am J Psychiatry 1992; 149: 620-625.
9. Steingart A, Hachinski VC, Lau C et al. Cognitive and neurologic findings in subjects with diffuse white matter lucencies on computed tomographic scan (leukoaraiosis). Arch Neurol 1987; 44: 32-35.
10. Cadelo M, Inzitari D, Pracucci G, Mascalchi M. Predictors of leukoaraiosis in elderly neurological patients. Cerebrovasc Dis 1991; 1: 345-351.
11. Longstreth WT, Manolio TA, Arnold A et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996; 27: 1274-1282.
12. Bennett DA, Gilley DW, Wilson RS, Huckman MS, Fox JH. Clinical correlates of high signal lesions on magnetic resonance imaging in Alzheimer's disease. J Neurol 1992; 239(4): 186-90.
13. Sitoh YY, Sitoh YY, Sahadevan S. Clinical significance of cerebral white matter lesions in older Asians with suspected dementia. Age Ageing 2004; 33(1): 67-71.
14. Lim PP, Sahadevan S, Choo GK, Anthony P. Burden of caregiving in mild to moderate dementia: an Asian experience. Int Psychogeriatr 1999; 11: 411-20.
15. Siew CW, Ho HK, Cheong SK, Tan BY, Lim FS, Emmanuel SC. Caregiver stress in activities of daily living-dependent elderly aged more than 65 years. Ann Acad Med Singapore 2003; 32: S69-71.
16. Thomas VS. Excess functional disability among demented subjects? Findings from the Canadian Study of Health and Aging. Dement Geriatr Cogn Disord 2001; 12(3): 206-10.
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical Diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
18. Roman GC, Tatemichi TK, Erkinjunnti T et al. Vascular dementia: diagnostic criteria for research study. Neurology 1993; 43: 250-260.
19. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings (1982) J Wricht, Boston, Bristol, London.
20. Mahoney FI, Barthel DW. Functional Evaluation: the Barthel Index. Md. State Med J 1965; 14: 61-65.
21. Wallin A, Blennow K, Gottfries CG, Langstrom G, Uhlemann C. White matter low attenuation on CT in dementia of the Alzheimer type and vasacular dementia. Acta Neurol Scand 1989; 80: 518-523.
22. Gupta SR, Naheedy MH, Young JC, Ghobrial M, Rubino FA, Hindo W. Periventricular white matter changes and dementia. Clinical, neuropsychological, radiological, and pathological correlation. Arch Neurol. 1988; 45(6): 637-41
23. Sheridan PL, Solomont J, Kowall N, Hausdorff JM. Influence of executive function on locomotor function: divided attention increases gait variability in Alzheimer's disease. J Am Geriatr Soc 2003; 51(11): 1633-7
24. Carlson MC, Fried LP, Xue QL, Bandeen-Roche K, Zeger SL, Brandt J. Association between executive attention and physical functional performance in community-dwelling older women. J Gerontol B Psychol Sci Soc Sci 1999; 54(5): S262-70.
25. Briley DP, Wasay M, Sergent S, Thomas S. Cerebral white matter changes (leukoaraiosis), stroke, and gait disturbance. J Am Geriatr Soc 1997; 45(12): 1434-8.
26. van Zagten M, Lodder J, Kessels F. Gait disorder and parkinsonian signs in patients with stroke related to small deep infarcts and white matter lesions. Mov Disord 1998; 13(1): 89-95
27. Boone KB, Miller BL, Lesser JM et al. Neuropsychological correlates of white matter lesions in healthy elderly subjects: a threshold effect. Arch Neurol 1992; 49: 549-554.
28. Hirono M, Kitagaki H, Kazui H, Hashimoto M, Mori E. Impact of white matter changes on clinical manifestation of Alzheimer's disease. A quantitative study. Stroke 2000; 31: 2182-2188.
29. Tarvonen-Schroder S, Roytta M, Raiha I, Kurki T, Rajala T, Sourander L. Clinical features of leukoaraiosis. J Neurol Neurosurg Psychiatry 1996; 60: 431-436.
30. Skoog I, Lernfelt B, Landahl S et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996; 347(9009): 1141-5.
31. Liao D, Cooper L, Cai J, Toole JF, Bryan NR, Hutchinson RG, Tyroler HA. Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study. Stroke 1996; 27(12): 2262-70